Medical Tubing MarketSize, Share & Industry Analysis, 2026-2034By TypeBy ApplicationBy End UserBy Manufacturing ProcessBy Sterilization Method

Medical tubing is a category of polymer and elastomer components manufactured to precise dimensional and biocompatibility standards for use in fluid transfer, drug delivery, and diagnostic devices. It takes the form of extruded single-lumen and multi-lumen tubing, catheters, cannulas, and custom-molded assemblies supplied in materials ranging from PVC and polyolefins to silicone and thermoplastic elastomers. Buyers are principally medical device manufacturers, contract manufacturers, and hospital supply networks that integrate these components into finished devices such as IV sets, catheters, feeding tubes, and drug delivery systems.

USD 12.6 billion of revenue was recorded in the global medical tubing market in 2025. By 2034 the figure reaches USD 24 billion, a compound annual growth rate of 7.41% through the forecast period, along a series that runs USD 8.35 billion in 2020, USD 11.42 billion in 2024, USD 13.55 billion in 2026 and USD 18.15 billion in 2030.

34% of 2025 revenue sits in PVC, worth USD 4.28 billion and rising to USD 6.72 billion at 28% by 2034, the largest type line in both years. Growth is fastest in Silicone at 9.85% and slowest in PVC at 5.11%. The lines gaining share are TPE & TPU and Silicone. PVC, Polyolefin and Other lose share without losing revenue.

By application, Bulk Disposable Tubing accounts for 38% of 2025 revenue at USD 4.79 billion, reaching USD 7.92 billion and 33% by 2034. Drug Delivery Systems grows faster at 9.99% against 5.75%, moving from 21% of revenue to 26% by 2034. This axis divides the same revenue as the type split instead of adding to it, so the two are read together and never summed.

USD 4.54 billion of 2025 revenue is generated in North America, 36% of the global total and the largest regional share; it reaches USD 7.68 billion by 2034. Europe is next at 28% and USD 3.53 billion, and Middle East and Africa last at 5%. Share shifts toward Asia Pacific, Latin America and Middle East and Africa over the forecast period, so the regional split repays a close reading.

The 2025 total is a triangulation of published figures and category proxies, short of a directly sourced total. Segment, regional and country splits are estimated on the same basis, which bounds the precision of the figures above. Coverage runs to five regions, five type lines and five segmentation axes across a fifteen-year window.

• Revenue grows from USD 12.6 billion in 2025 to USD 24 billion in 2034, a compound annual rate of 7.41%, having reached USD 11.42 billion in 2024 from USD 8.35 billion in 2020.
• The largest line by type is PVC, worth USD 4.28 billion and 34% of revenue in 2025, rising to USD 6.72 billion and 28% by 2034.
• Fastest growth on the type axis belongs to Silicone: 9.85% a year, USD 2.27 billion to USD 5.28 billion, and a share moving from 18% to 22%.
• Scenario range for 2034 runs from USD 21 billion in the bear case to USD 27 billion in the bull case, against a base-case USD 24 billion, the spread a plan built on this forecast has to absorb.
• North America holds 36% of global revenue in 2025 at USD 4.54 billion, the largest of the five regions tracked, and reaches USD 7.68 billion by 2034.
• The United States accounts for 78% of North America in the base year, worth USD 3.54 billion in 2025 and reaching USD 5.91 billion by 2034, the worked country example carried through that region's chapters.
• Every line on all five segmentation axes and in each of the five regions carries its own revenue, share and growth rate for all fifteen years, 2020 through 2034, on a 2025 base.

Read across the forecast period, the global medical tubing market shows movement in three places: type composition, regional weight, and the 7.41% rate applied to the whole.

The direction of the market is not in question in any of the three. Each line and each region grows in revenue terms; what separates them is which takes the larger part of the growth.

Composition shifts on the type axis. Silicone grows at 9.85% across 2026-2034 against 5.11% for PVC, the widest spread on the type axis. Over the forecast period that moves Silicone from 18% of revenue to 22%, and PVC from 34% to 28%. Neither contracts: USD 2.27 billion becomes USD 5.28 billion, USD 4.28 billion becomes USD 6.72 billion. What the spread decides is which of them a supplier's revenue is exposed to.

Asia Pacific, Latin America and Middle East and Africa gain regional share. Asia Pacific moves from 24% of revenue in 2025 to 30% in 2034, worth USD 3.02 billion rising to USD 7.2 billion; Latin America moves from 7% of revenue in 2025 to 7.5% in 2034, worth USD 0.88 billion rising to USD 1.8 billion; Middle East and Africa moves from 5% of revenue in 2025 to 5.5% in 2034, worth USD 0.63 billion rising to USD 1.32 billion. The offsetting side is North America at 36% moving to 32%, Europe at 28% moving to 25%, none of which contracts. The practical consequence is that regional weighting decides whether a participant matches the market rate or trails it, regardless of how its own revenue reads.

Fifteen years without a discontinuity. Fifteen years of revenue run USD 8.35 billion in 2020, USD 11.42 billion in 2024, USD 12.6 billion in 2025, USD 13.55 billion in 2026, USD 18.15 billion in 2030 and USD 24 billion in 2034. The forecast rate of 7.41% sits against 8.58% over the historical period, so the projection extends an observed trend instead of proposing a new one. The risk in the number sits in the mix assumptions, not in whether the market grows at all, which is where the type and regional sections come in.

Silicone adds the most incremental growth

Three sources account for the growth to 2034: 7.41% compounding across the base, share moving toward the faster type lines, and above-market expansion in the leading regions.

The bear case and what drives it

Upside case: USD 27 billion by 2034

One type line carries the market

USD 4.54 billion of 2025 revenue is generated in North America, 36% of the global medical tubing market with USD 7.68 billion projected for 2034. It is a dominant region on this axis, first by revenue throughout the period.

32% of global revenue sits here in 2034, below the 2025 level, while nothing contracts here; other regions simply grow faster, which shows up as relative weight, not as falling revenue.

Segment composition follows the global pattern: PVC largest at 34% of 2025 revenue, Silicone fastest at 9.85%. Revenue for North America is broken out by every segmentation axis and by country in the full report.

USD 3.54 billion of North America's 2025 revenue is generated in the United States, the region's largest market, reaching USD 5.91 billion by 2034. Carrying 78% of the region in the base year, it sets North America's direction instead of merely contributing to it. Set against USD 4.54 billion and USD 7.68 billion for the region, it is why this market, and not a smaller one, is the one reported in full.

The type pattern in the United States is the global one: 34% of 2025 revenue in PVC, 28% by 2034, against 9.85% growth in Silicone taking it from 18% to 22%. Since 78% of North America's revenue is generated here, the regional numbers inherit this market's mix instead of smoothing it out. Revenue by type for the United States is reported separately in the full report.

The Food and Drug Administration regulates medical tubing as a device or device component under the Federal Food, Drug, and Cosmetic Act. Classification determines the pathway a supplier must follow: many tubing products clear through a premarket notification, while higher-risk applications require premarket approval. Manufacturers must operate under the Quality System Regulation, maintaining design controls and documented process validation, and must meet biocompatibility expectations drawn from recognized ISO standards for materials in patient contact. Labeling must identify intended use, material composition, and sterility status where applicable, and any change in polymer formulation or indication can trigger a new submission before the product reaches the market.

Competition in the United States runs between the suppliers this study tracks: Saint-Gobain Performance Plastics, W.L.Gore & Associates, Teleflex, Nordson Corporation, B. Braun, Freudenberg Group, Zeus Industrial Products, Raumedic, Tekni-Plex, Lubrizol (Vesta), MDC Industries, FBK Medical Tubing, Inc., Putnam Plastics, LVD Biotech, Teel Plastics Inc., Ap Technologies, Microlumen, A.P. Extrusion, Polyzen and Optinova. Two different problems sit on the same axis: holding PVC at 34% of 2025 revenue, and taking Silicone while it grows at 9.85%. Per-company positioning and share at country level are in the full report only.

5.4% of global revenue is generated in Canada; USD 0.68 billion in 2025, reaching USD 1.15 billion in 2034, and 15% of North America.

In Europe, 28% of global revenue puts 2025 at USD 3.53 billion and reaches USD 6 billion by 2034. By revenue it sits second across the study, and the ranking does not change between 2025 and 2034.

By 2034 the share stands at 25%, and the region keeps growing in absolute terms while others expand faster, a change in relative weight, not a decline in demand.

Within the region the type split tracks the global one; 34% of 2025 revenue in PVC, fastest growth of 9.85% in Silicone. Revenue for Europe is broken out by every segmentation axis and by country in the full report.

The largest single market in Europe is Germany, at USD 1.06 billion in 2025 and USD 1.74 billion in 2034. 30% of the region in the base year makes it the largest market here without making it the region. Against regional totals of USD 3.53 billion in 2025 and USD 6 billion in 2034, it is the country the full report breaks out in detail.

Demand in Germany follows the type mix reported at global level: PVC is the largest line at 34% of 2025 revenue, moving to 28% by 2034, while Silicone grows fastest at 9.85% and takes its share from 18% to 22%. Its 30% weight in Europe means those movements carry straight into the regional totals. The full report reports Germany by type separately.

In Germany, medical tubing used in patient care falls under the EU Medical Device Regulation, enforced nationally through the Medical Devices Act. A manufacturer must assign a risk class and submit to a Notified Body for conformity assessment before affixing the CE mark, with tubing intended for prolonged bodily contact typically facing closer scrutiny than short-term accessories. Conformity is demonstrated against harmonized standards covering biological evaluation and quality management systems, and a technical file must document material traceability and sterilization validation. The Federal Institute for Drugs and Medical Devices maintains market surveillance and can request corrective action where nonconformity is identified.

In Germany the field is Saint-Gobain Performance Plastics, W.L.Gore & Associates, Teleflex, Nordson Corporation, B. Braun, Freudenberg Group, Zeus Industrial Products, Raumedic, Tekni-Plex, Lubrizol (Vesta), MDC Industries, FBK Medical Tubing, Inc., Putnam Plastics, LVD Biotech, Teel Plastics Inc., Ap Technologies, Microlumen, A.P. Extrusion, Polyzen and Optinova. Volume sits in PVC at 34% of 2025 revenue; movement sits in Silicone at 9.85% growth. That makes Europe a 28% share of 2025 global revenue, USD 3.53 billion rising to USD 6 billion, for any supplier deciding where to concentrate.

Within Europe, France accounts for 20.1% of regional revenue and 5.6% of the global total, worth USD 0.71 billion in 2025 and USD 1.17 billion by 2034.

The United Kingdom is sized at USD 0.64 billion in 2025, rising to USD 1.05 billion by 2034; 5.1% of global revenue and 18.1% of Europe. It is reported separately from Germany across every segmentation axis in the full report.

In Asia Pacific, 24% of global revenue puts 2025 at USD 3.02 billion rising to USD 7.2 billion in 2034. It is a leading region on this axis, third by revenue throughout the period.

Its share rises to 30% over the forecast period, so the region grows faster than the market's 7.41% and takes a larger part of the revenue added by 2034 than its 2025 weight implies.

PVC leads here as it does globally, at 34% of 2025 revenue, and Silicone again grows fastest at 9.85%. Revenue for Asia Pacific is broken out by every segmentation axis and by country in the full report.

The largest single market in Asia Pacific is China, at USD 1.15 billion in 2025 and USD 2.88 billion in 2034. 38.1% of the region in the base year makes it the largest market here without making it the region. Regional revenue of USD 3.02 billion in 2025 and USD 7.2 billion in 2034 sits around it, and it is the country used wherever the full report cuts a figure by geography.

China buys along the same lines as the market globally; PVC first at 34% of 2025 revenue and 28% in 2034, Silicone fastest at 9.85% on a share moving from 18% to 22%. With 38.1% of Asia Pacific concentrated here, a change in this country's mix is visible in the regional figures instead of being diluted by its neighbours. Revenue by type for China is reported separately in the full report.

China's National Medical Products Administration classifies medical tubing according to the degree of risk it poses in clinical use, with the classification determining whether a product proceeds through simple filing or full registration review. Registration requires a technical dossier demonstrating compliance with applicable national and industry standards covering material safety and performance, along with evidence from a designated testing institution. Imported tubing typically needs a local agent to manage registration and post-market obligations. Labeling must appear in Chinese, state intended use and material composition, and manufacturers must maintain a quality management system consistent with national good manufacturing practice requirements throughout the product's registered life.

Competition in China runs between the suppliers this study tracks: Saint-Gobain Performance Plastics, W.L.Gore & Associates, Teleflex, Nordson Corporation, B. Braun, Freudenberg Group, Zeus Industrial Products, Raumedic, Tekni-Plex, Lubrizol (Vesta), MDC Industries, FBK Medical Tubing, Inc., Putnam Plastics, LVD Biotech, Teel Plastics Inc., Ap Technologies, Microlumen, A.P. Extrusion, Polyzen and Optinova. Two different problems sit on the same axis: holding PVC at 34% of 2025 revenue, and taking Silicone while it grows at 9.85%. The commercial size of that position is USD 3.02 billion in 2025 and USD 7.2 billion by 2034, 24% of the global total in the base year.

Japan is sized at USD 0.66 billion in 2025, rising to USD 1.37 billion by 2034; 5.2% of global revenue and 21.9% of Asia Pacific. It is reported separately from China across every segmentation axis in the full report.

Within Asia Pacific, India accounts for 14.9% of regional revenue and 3.6% of the global total, worth USD 0.45 billion in 2025 and USD 1.37 billion by 2034.

7% of the global medical tubing market sits in Latin America in 2025, worth USD 0.88 billion on the way to USD 1.8 billion by 2034. Among the five regions it ranks fourth by revenue in both years.

7.5% of global revenue sits here by 2034, up from the 2025 level, on growth above the market's own 7.41%, and with a bigger contribution to the revenue added over the period than the base-year figure suggests.

PVC leads here as it does globally, at 34% of 2025 revenue, and Silicone again grows fastest at 9.85%. Latin America is reported axis by axis and country by country in the full study.

USD 0.4 billion of Latin America's 2025 revenue is generated in Brazil, the region's largest market, reaching USD 0.83 billion by 2034. Its 45.5% of base-year regional revenue leads the region, though enough sits elsewhere that Latin America is not a proxy for it. Against regional totals of USD 0.88 billion in 2025 and USD 1.8 billion in 2034, it is the country the full report breaks out in detail.

The type pattern in Brazil is the global one: 34% of 2025 revenue in PVC, 28% by 2034, against 9.85% growth in Silicone taking it from 18% to 22%. Since 45.5% of Latin America's revenue is generated here, the regional numbers inherit this market's mix instead of smoothing it out. The full report reports Brazil by type separately.

Brazil's health surveillance agency, ANVISA, oversees medical tubing under its medical device framework, assigning a risk classification that determines whether registration or the lighter cadastro route applies. A supplier must show conformity with Good Manufacturing Practice certification, typically verified through facility inspection, and must submit technical documentation covering material composition and intended clinical use. Labeling must appear in Portuguese and identify the manufacturer, importer where applicable, and any special handling or sterility conditions. ANVISA periodically reviews registered devices and can suspend market authorization if post-market surveillance reveals safety concerns or if manufacturing conditions no longer meet certified standards.

Saint-Gobain Performance Plastics, W.L.Gore & Associates, Teleflex, Nordson Corporation, B. Braun, Freudenberg Group, Zeus Industrial Products, Raumedic, Tekni-Plex, Lubrizol (Vesta), MDC Industries, FBK Medical Tubing, Inc., Putnam Plastics, LVD Biotech, Teel Plastics Inc., Ap Technologies, Microlumen, A.P. Extrusion, Polyzen and Optinova are the suppliers covered in Brazil. PVC, at 34% of 2025 revenue, is where the volume sits, and Silicone, growing at 9.85%, is where position changes hands over the forecast period. That makes Latin America a 7% share of 2025 global revenue, USD 0.88 billion rising to USD 1.8 billion, for any supplier deciding where to concentrate.

2.1% of global revenue is generated in Mexico; USD 0.26 billion in 2025, reaching USD 0.54 billion in 2034, and 29.5% of Latin America.

In Middle East and Africa, 5% of global revenue puts 2025 at USD 0.63 billion rising to USD 1.32 billion in 2034. It is a marginal region on this axis, fifth by revenue throughout the period.

Its share rises to 5.5% over the forecast period, at a pace above the 7.41% global rate, so this region warrants separate treatment and should not be scaled off the total.

The type mix reported at global level applies here, with PVC the largest line at 34% of 2025 revenue and Silicone the fastest-growing at 9.85%. Revenue for Middle East and Africa is broken out by every segmentation axis and by country in the full report.

USD 0.22 billion of Middle East and Africa's 2025 revenue is generated in Saudi Arabia, the region's largest market, reaching USD 0.48 billion by 2034. It accounts for 34.9% of regional revenue in the base year, the largest single share without dominating the region outright. Against regional totals of USD 0.63 billion in 2025 and USD 1.32 billion in 2034, it is the country the full report breaks out in detail.

Saudi Arabia buys along the same lines as the market globally; PVC first at 34% of 2025 revenue and 28% in 2034, Silicone fastest at 9.85% on a share moving from 18% to 22%. With 34.9% of Middle East and Africa concentrated here, a change in this country's mix is visible in the regional figures instead of being diluted by its neighbours. The full report reports Saudi Arabia by type separately.

In Saudi Arabia, the Saudi Food and Drug Authority regulates medical tubing through its medical device framework, requiring an authorized local representative to manage registration on behalf of any foreign manufacturer. Devices are classified by risk, and registration depends on demonstrated conformity with recognized international quality and safety standards, often accepted through reliance on approvals already granted by comparable regulatory authorities abroad. Technical documentation must cover material biocompatibility and manufacturing controls, and labeling must be presented in Arabic alongside the original language, stating intended use and handling instructions. Ongoing market presence depends on maintaining valid registration and responding to any safety notice the authority issues.

Saint-Gobain Performance Plastics, W.L.Gore & Associates, Teleflex, Nordson Corporation, B. Braun, Freudenberg Group, Zeus Industrial Products, Raumedic, Tekni-Plex, Lubrizol (Vesta), MDC Industries, FBK Medical Tubing, Inc., Putnam Plastics, LVD Biotech, Teel Plastics Inc., Ap Technologies, Microlumen, A.P. Extrusion, Polyzen and Optinova are the suppliers covered in Saudi Arabia. PVC, at 34% of 2025 revenue, is where the volume sits, and Silicone, growing at 9.85%, is where position changes hands over the forecast period. A supplier weighted toward Middle East and Africa is competing over a base of USD 0.63 billion in 2025 reaching USD 1.32 billion by 2034, 5% of global revenue at the start of that period.

1.1% of global revenue is generated in South Africa; USD 0.14 billion in 2025, reaching USD 0.29 billion in 2034, and 22.2% of Middle East and Africa.

Request this sample to see the full data tables and segment-level detail behind this analysis.

This report assesses the market across every segment, with revenue and a growth rate for each line in each year of the study period. It covers the drivers, trends, opportunities, restraints and challenges shaping growth, the competitive landscape and the companies profiled, and the research methodology behind every estimate. Segmentation is reported by Type, Application, End User, Manufacturing Process, Sterilization Method, and regional analysis covers North America, Europe, Asia Pacific, Latin America, Middle East and Africa, each broken out by country.